PMCB
PharmaCyte Biotech Inc
NASDAQ: PMCB · HEALTHCARE · BIOTECHNOLOGY
$0.75
-1.32% today
Updated 2026-04-29
Market cap
$8.05M
P/E ratio
—
P/S ratio
12,904.41x
EPS (TTM)
$-0.89
Dividend yield
—
52W range
$1 – $2
Volume
0.1M
PharmaCyte Biotech Inc (PMCB) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $537038.00 | $1.17M | $1.19M | $653134.00 | $262932.00 | $125997.00 | $66558.00 | $12160.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | +117.9% | +1.7% | -45.1% | -59.7% | -52.1% | -47.2% | -81.7% | -100.0% | — | — | — | — | — | — | — | — | — | — | — |
| Cost of revenue | $488.00 | $171007.00 | $266202.00 | $427410.00 | $228659.00 | $32104.00 | $19383.00 | $9620.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — |
| Gross profit | $537038.00 | $998651.00 | $923752.00 | $225724.00 | $34273.00 | $93893.00 | $47175.00 | $2540.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — |
| Gross margin | 100.0% | 85.4% | 77.6% | 34.6% | 13.0% | 74.5% | 70.9% | 20.9% | — | — | — | — | — | — | — | — | — | — | — | — |
| R&D | $119008.00 | $133835.00 | $412882.00 | $473514.00 | $492460.00 | $9209.00 | — | — | $323.00 | $3.48M | $1.41M | $1.18M | $2.00M | $460052.00 | $301221.00 | $916249.00 | $690937.00 | $468536.00 | $407431.00 | $438416.00 |
| SG&A | $6.56M | $4.47M | $4.26M | $5.33M | $1.24M | $471424.00 | $824329.00 | $901781.00 | $18.11M | $9.99M | $4.67M | $3.26M | $4.98M | $3.64M | $1.94M | $2.71M | $2.16M | $4.75M | $4.79M | $3.94M |
| Operating income | $-7.33M | $-3.61M | $-3.75M | $-6.18M | $-2.11M | $-388000.00 | $-1.95M | $-1.68M | $-18.98M | $-13.70M | $-6.07M | $-4.44M | $-6.98M | $-4.10M | $-3.83M | $-3.62M | $-4.39M | $-6.46M | $-6.52M | $-4.38M |
| Operating margin | -1365.8% | -308.3% | -315.0% | -945.7% | -802.1% | -307.9% | -2928.3% | -13848.7% | — | — | — | — | — | — | — | — | — | — | — | — |
| EBITDA | $-7.33M | $-3.61M | $-3.74M | $-6.15M | $-5.58M | $-348000.00 | $-1.63M | $-1.68M | $-27.23M | $-9.92M | $-6.07M | $-4.44M | $-6.83M | $-4.10M | $-40.00 | $-3.55M | $-4.24M | $-4.32M | $6.85M | $30.66M |
| EBITDA margin | -1365.8% | -308.2% | -314.5% | -941.3% | -2123.9% | -276.2% | -2453.5% | -13848.7% | — | — | — | — | — | — | — | — | — | — | — | — |
| EBIT | $-7.34M | $-3.61M | $-3.75M | $-6.18M | $-5.70M | $-388688.00 | $-1.66M | $-1.69M | $-21.34M | $-10.42M | $-6.07M | $-4.44M | $-6.98M | $-4.10M | $-3.83M | $-7.25M | $-8.63M | $-10.77M | $333761.00 | $-4.38T |
| Interest expense | $0.00 | $0.00 | $0.00 | $36471.00 | $292556.00 | $171663.00 | $241246.00 | $154416.00 | $21053.00 | $4938.00 | $1191.00 | $1539.00 | $0.00 | $0.00 | $453.00 | $3046.00 | $509.00 | $0.00 | — | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-9.38M | $-3.61M | $-3.79M | $-6.04M | $-5.99M | $-1.40M | $-1.90M | $-1.60M | $-27.25M | $-10.86M | $-6.06M | $-4.44M | $-6.83M | $-4.07M | $-3.83M | $-3.55M | $-4.24M | $-4.32M | $333763.00 | $30.66M |
| Net income growth (YoY) | — | +61.5% | -4.9% | -59.3% | +0.8% | +76.7% | -35.8% | +15.9% | -1605.5% | +60.2% | +44.1% | +26.7% | -53.7% | +40.4% | +5.9% | +7.1% | -19.3% | -1.8% | +107.7% | +9085.0% |
| Profit margin | -1747.5% | -308.9% | -318.7% | -925.1% | -2278.9% | -1109.6% | -2853.2% | -13141.4% | — | — | — | — | — | — | — | — | — | — | — | — |